Trxade Group Stock

Trxade Group FCF Yield

The Free Cash Flow Yield of Trxade Group (MEDS) as of Aug 10, 2026 is -15.61 %. In the previous year, Free Cash Flow Yield was -14.88 % — a change of 4.90% (lower).

FCF Yield

-15.61 %

YoY

4.90%

Last updated:

Free Cash Flow Yield of Trxade Group is 2026 -15.61 % . Free Cash Flow Yield of Trxade Group was 2025 -14.88 % . It decreases by 4.90% lower compared to the previous year.
Access this data via the Eulerpool API

Trxade Group Stock analysis

What does Trxade Group do? The Trxade Group Inc is a US-American company that was founded in 2010 and has its headquarters in Tampa, Florida. The company is engaged in the development and operation of an online platform for trading pharmaceuticals and medical products for healthcare facilities and pharmacies. The business model of Trxade is to facilitate and streamline the purchase of pharmaceuticals and medical products for smaller healthcare facilities and pharmacies. To do this, the company operates an online platform that allows customers to order their needed products directly from various suppliers. By using the platform, customers can save time and costs as they no longer have to inquire with various suppliers and place individual orders for products. Instead, they can handle all their orders through the platform and thereby have access to a wider range of products and better prices. Trxade offers its customers various divisions. The main division is the trade of generic pharmaceuticals. Here, the company works closely with various suppliers and manufacturers to offer its customers a wide range of medications. Generic pharmaceuticals are usually cheaper than brand-name medications, allowing the company's customers to save costs. In addition, Trxade also offers other medical products such as vaccines, diagnostics, and medical accessories. Another business area of Trxade is the operation of pharmacies. The company operates several pharmacies under the brand name "Bonum Health," which offer a wide range of medical services. These include, for example, telehealth services, where patients can receive medical advice and assistance from licensed doctors via video call. The pharmacies also offer a wide range of prescription and over-the-counter medications. Trxade has undergone remarkable development in recent years. In 2016, the company went public and in 2019 had a revenue of around 10 million US dollars. Trxade now has over 11,000 registered customers and collaborates with over 450 suppliers and manufacturers. Overall, Trxade is an innovative company focused on simplifying and improving the trade of pharmaceuticals and medical products for smaller healthcare facilities and pharmacies. With its wide range of generic pharmaceuticals, medical accessories, and telehealth services, the company has established a strong position in the market and is expected to continue growing in the coming years. Trxade Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Trxade Group stock

Free Cash Flow Yield of Trxade Group is -15.61 % in 2026.

Free Cash Flow Yield of Trxade Group changed from -14.88 % to -15.61 %, representing a 4.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Trxade Group since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Trxade Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Trxade Group

All Key Metrics — Trxade Group